EMBL spin-off Velabs Therapeutics to cooperate with Chiome Bioscience in the field of GPCR-specific functional antibody screening EMBL spin-off Velabs Therapeutics to cooperate with Chiome Bioscience in the field of GPCR-specific functional antibody screening April 24, 2019 General Read more
Prioritising cancer drug targets using CRISPR Prioritising cancer drug targets using CRISPR April 11, 2019 General Read more
